In 2002, in response to the NIH Roadmap to Molecular Libraries and Imaging, we conceived the process and now have fully established a P50 High Throughput Screening Robotics Core. The new Core represents a multi-departmental effort with fiscal support for establishing the Core coming from P50 funds in combination with the Department of Radiology, Department of Molecular Biology & Pharmacology, and Department of Cell Biology as well as the Howard Hughes Medical Institute. The Dean of Washington University School of Medicine as well as the Director of the Washington University Siteman Cancer Center joined our effort with the commitment of additional funds for further development of the resource. Overall, nearly $2M has been invested in the establishment of this resource. This Core serves as an outstanding on-going example of how our P50 program has leveraged university resources and continues to stimulate interdisciplinary molecular imaging activity throughout the WU campus. Functionally and symbolically, Drs. Helen Piwnica-Worms (Cell Biology), Rafi Kopan (Molecular Biology &Pharmacology), and David Piwnica-Worms (Radiology ) serve as Core Co-Directors with shared administration and scientific oversight of Core activities. This Core is housed in the McDonnell Sciences Building, Room 316, across the street from the East Building Imaging Annex, site of many of the Molecular Imaging Center collaborative activities. Construction of the room and instrument requirements was finished in 2005 and installations of the Beckman Coulter BioMek FX liquid handler as well as an ORCA robot on a 6 ft rail were completed in the summer/fall of 2005. A bio-barrier entryway was constructed and positive-pressure, HEPA filtered air circulation has been installed. Integrated readout and cell culture stations are included with the imaging and analysis instruments. This innovative Core was founded on molecular imaging platforms for readout of a wide range of bio-assays and underpins three of the Research Projects in this application. This Core assures that the personnel and resources for high throughput screening are available to all our ICMIC investigators. Jayne Marasa, senior Core lab manager, directs day-to-day experiments and has optimized several protocols and logistical requirements for our first projects in high throughput screening. Exciting data are now coming on-line during the summer 2006. The Core allows for automated screening of cells cultured in 96 or 384 plate formats and can be applied to multiple investigator-initiated molecular imaging applications arising from P50 investigators and throughout the university community. The applications include: 1) small molecule screens applied to cells engineered by WU investigators for imaging and therapeutic drug leads. 2) small molecule or peptide screens to identify enzyme inhibitors (directed against high priority proteases, kinases, phosphatases, etc.) or modulators of protein-protein interactions. 3) genome-wide siRNA library screens against kinases, phosphatases and E3-ligases in human cells targeting signal transduction, cell growth or cell death responses.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA094056-11
Application #
8233028
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-01-01
Budget End
2011-12-31
Support Year
11
Fiscal Year
2011
Total Cost
$220,214
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Meinerz, Kelsey; Beeman, Scott C; Duan, Chong et al. (2018) Bayesian Modeling of NMR Data: Quantifying Longitudinal Relaxation in Vivo, and in Vitro with a Tissue-Water-Relaxation Mimic (Crosslinked Bovine Serum Albumin). Appl Magn Reson 49:3-24
Zheleznyak, Alexander; Shokeen, Monica; Achilefu, Samuel (2018) Nanotherapeutics for multiple myeloma. Wiley Interdiscip Rev Nanomed Nanobiotechnol 10:e1526
Choi, Jaebok; Cooper, Matthew L; Staser, Karl et al. (2018) Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease. Leukemia 32:2483-2494
Kotagiri, Nalinikanth; Cooper, Matthew L; Rettig, Michael et al. (2018) Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer. Nat Commun 9:275
Murali, Bhavna; Ren, Qihao; Luo, Xianmin et al. (2018) Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss. Cancer Res 78:5618-5630
Miller, Jessica; Wang, Steven T; Orukari, Inema et al. (2018) Perfusion-based fluorescence imaging method delineates diverse organs and identifies multifocal tumors using generic near-infrared molecular probes. J Biophotonics 11:e201700232
Zacharias, Niki; Lee, Jaehyuk; Ramachandran, Sumankalai et al. (2018) Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo. Mol Imaging Biol :
Cherian, Mathew A; Olson, Sydney; Sundaramoorthi, Hemalatha et al. (2018) An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia. J Biol Chem 293:6844-6858
Hövener, Jan-Bernd; Pravdivtsev, Andrey N; Kidd, Bryce et al. (2018) Parahydrogen-Based Hyperpolarization for Biomedicine. Angew Chem Int Ed Engl 57:11140-11162
Bauerle, Kevin T; Hutson, Irina; Scheller, Erica L et al. (2018) Glucocorticoid Receptor Signaling Is Not Required for In Vivo Adipogenesis. Endocrinology 159:2050-2061

Showing the most recent 10 out of 283 publications